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ABSTRACT 
 
The aim of this clinical trial was to examine the clinical and biochemical efficacy of diode laser as an adjunct to 
scaling and root planing (SRP). 30 subjects were selected on basis of inclusion criteria and were categorized into 
two groups. After selection of subjects, 15 patients were included under control group and 15 patients were included 
under test group randomly. Plaque index, gingival index, bleeding on probing, probing depth, and clinical 
attachment level were measured at baseline, 1 month and 3 months after treatment. Interleukin-6 (IL-6), component 
of gingival crevicular fluid were analyzed by enzyme-linked immunosorbent assay. Better outcome was observed in 
test group compared to control group in full-mouth clinical parameters. The total amount of IL-6 value was 
decreased (p<0.05) after treatment in both the test as well as the control groups (p<0.05). The Diode laser provided 
significant improvements in clinical parameters which showed its positive effect on non surgical periodontal therapy 
Keywords: Chronic periodontitis, Gingival crevicular fluid, Interleukin-6, Diode laser 
Introduction 
Chronic periodontitis (CP) is an infectious disease 
caused by periodontal pathogens resulting in 
inflammation, attachment loss, bone resorption, and 
characterized by pocket formation and/or gingival 
recession[1].The essential objective of periodontal 
treatment is to decrease or eliminate the responsible 
periopathogens, by means of removing bacterial 
deposits from the tooth surface. Conventional 
mechanical debridement (i.e SRP) is considered to be 
the gold standard for inflammatory periodontal disease 
treatment[2].Mechanical therapy alone may fail to 
eliminate pathogenic bacterial niches in the soft tissue 
and in areas that are inaccessible to periodontal 
instruments, such as deep pockets, furcation areas, and 
root depressions[3]. In deep pockets, periodontopathic 
bacteria can persist after SRP. This situation can lead 
to the recolonization of treated sites. 
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Moreover, the use of SRP in the treatment of CP may 
result in a moderate and temporary shift in the 
composition of the microbial flora particularly in deep 
pockets where periodontopathic bacteria can persist 
after SRP. This situation can lead to the recolonization 
of treated sites[4] Limitations in conventional non-
surgical periodontal therapy have led to the exploration 
of other treatment options to improve clinical 
outcomes. Lasers of various wavelengths have been 
proposed as an alternative treatments for non-surgical 
periodontal therapy[5].The bactericidal and detoxifying 
effects of the diode laser during non-surgical 
periodontal treatment have been documented. Lasers 
can be effective on oral microbial species and 
“disinfect” the periodontal environment. Lasers may 
also modulate the oral inflammatory response.
  
Diode 
laser (780 nm) has been shown to inhibit IL-6 in 
lipopolysaccharide stimulated macrophages[1] 
The biochemical analysis of GCF offers a non invasive 
approach for assessing the host response in individuals 
with periodontitis[6] Spontaneous production of IL-6 
has been found in mononuclear cells isolated from 
inflamed gingival tissues of patients with Periodontitis. 
IL-6 m-RNA expressing cells are observed in both 
lymphocytes and non- lymphoid cells in inflamed 
gingival tissues, but not in healthy gingival tissue. IL-6 
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is produced in inflamed gingival tissues and is involved 
in the initiation or prognosis of periodontitis[7]
 
IL-6 is a pleiotropic cytokine with a broad range of 
humoral and cellular immune effects, relating to 
inflammation, host defense and tissue injury promoting 
the osteoclast differentiation from progenitor cells.
8
 
Thus the aim of the study was to assess the efficacy of 
diode laser as an adjunct to the non-surgical 
periodontal therapy (scaling and root planing) for the 
treatment of chronic periodontitis and to compare the 
efffectiveness of SRP+laser and with SRP alone and 
check the biochemical analysis of IL6 present in both 
the groups in patients of chronic periodontitis. 
Material and method 
Participants and study design 
Patients with in age range of 18-55 years of both the 
sexes were selected from the Out Patient Department 
of Periodontology, after the approval of the ethical 
committee of the DJ College of Dental Sciences and 
Research, Modinagar, Uttar Pradesh.  Each patient was 
given a detailed verbal and written description of the 
study. They were  required to sign an informed consent 
form prior to commencement of the study. Patients 
who were diagnosed with chronic periodontitis in the 
Oral Diagnosis and Radiology Department were 
randomly assigned in 30 subjects and divided into 2 
groups. After subject selection 15 patients were 
randomly assigned to first group that is the contol 
group, and remaining 15 patients were assigned as 
second group. The patients will be categorized into 2 
groups- GROUP 1: patients with chronic generalized 
periodontitis receiving therapy using diode laser and 
SRP. GROUP 2: patients: receiving therapy using only 
SRP. Patients were included both male and female 
from the range of 18-55 years and presence of chronic 
periodontitis (at least 7 teeth with periodontal pocket 
deeper than 4 mm.). Exclusion criteria were 
periodontal treatment received for the last 1 year; 
systemic diseases that could influence the outcome of 
the therapy, pregnancy, smoking, History of 
medication in previous 5 months. 
Clinical parameters 
This would be followed by evaluation on the basis of 
periodontal parameters and biochemical study. Clinical 
parameters include plaque index, gingival index, 
gingival bleeding index, probing depth and Clinical 
attachment level. Follow up would be done at baseline, 
1 month and 3 months. Biochemical sampling will be 
performed for the evaluation of IL-6 levels using 
ELISA kit at baseline, 1 month and 3 month. 
Clinical procedure 
In control group, at baseline Patient came to the 
department of periodontology and implantology and 
had undergone supragingival scaling, and GCF sample 
was taken. This was followed by a comprehensive 
phase I therapy which included patient education and 
motivation, plaque control, scaling and root planing. 
The patients were given oral hygiene instructions and 
then advised of meticulous home care including 
mechanical plaque control and patient were recalled 
after 1 month and 3 month. In test group One week 
after baseline, subgingival scaling and root planing 
under local anesthesia was performed in a single 
appointment for each patient in all groups using an 
ultrasonic scaler and hand instruments. SRP and diode 
laser therapy was performed in the same visit. 
Clinical measurements 
On the first visit, detailed case history including 
clinical parameters [gingival index, plaque index, 
gingival  bleeding index, probing pocket depth, clinical 
attachment level (with the help of UNC-15 probe to the 
nearest millimeter), GCF samples were taken and 
Interleukin-6 levels were recorded. Scaling and root 
planning were performed in both the groups. No 
antibiotics or anti-plaque and anti-inflammatory agents 
were prescribed after treatment. This was followed by a 
comprehensive phase I therapy which included patient 
education and motivation, plaque control, scaling and 
root planning.One month and three month later these 
measurements (GI, PI, GBI, PD, CAL) and GCF 
sampling were repeated and Interleukin-6 were 
assessed by means of commercial Enzyme linked 
immunosorbent assay. 
Laser procedure 
In test group, 1 week before treatment, supragingival 
scaling was performed for each patient in  using hand 
instruments (Gracey curettes, Hu-Friedy, Chicago, IL, 
USA) and ultrasonic devices. Full-mouth subgingival 
scaling and root planing under local anesthesia was 
performed in a single appointment for each patient in 
all groups using an ultrasonic scaler and hand 
instruments. SRP and diode laser therapy was 
performed in the same visit. All treatments were 
performed under local anesthesia. Laser treatment was 
performed by using a 980 nm indium– gallium–
aluminum–phosphate diode laser. The periodontal 
pocket was set at 1.5 W with a pulse interval of 20 ms 
and pulse length of 20 ms delivering 20 s/ cm2 and 15 
J/cm2 of energy. Irradiation was accomplished with a 
300 μm fiber optic delivery system. The fibre was 
inserted into the periodontal pocket base in parallel 
alignment with the root surface, the device was 
activated, and the fiber was slowly moved from apical 
to coronal in a sweeping motion during the laser light 
emission. This was done mesially to distally at the 
buccal aspect for 10 s and distally to mesially at the 
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lingual aspect for 10 s reaching a total of 20 s for each 
tooth. The periodontal pocket was irrigated with saline 
solution after each session of irradiation. In order to 
control for the same conditions, pockets were also 
rinsed with saline after SRP in the control group. Both 
patients and the operator wore protective glasses during 
laser application were performed. 
Collection of GCF 
Each GCF sample was  collected for 15 seconds by 
calibrated volumetric microcapillary  pipettes which 
were inserted in the gingival sulcus immediately after 
the area has been isolated  with cotton rolls, air dried, 
and supragingival plaque has been removed with a 
sterile Gracey curette. The pipettes with GCF were 
coded for patient details and were placed in 
polypropylene tube and immediately transferred to 
plastic vial and stored at -20
0 
C prior to transportation 
to the lab. Polypropylene tube were immediately 
transferred to plastic vial then stored at -70°C till the 
time of assay. Microcapillary pipettes contaminated 
with blood and saliva were excluded from the sampled 
group. GCF sample were collected again after one 
month and 3 month respectively. 
GCF analysis 
Biochemical analysis of GCF samples was done to 
estimate the level of  Interleukin-6. 
IL-6 concentration was measured according to 
manufacturer’s instructions using commercially 
available sensitive ELISA kit (Boster Biological 
Technology co.LTD) 
Principle of the assay 
Boster’s human IL-6ELISA Kit is based on standard 
sandwich enzyme-linked immune-sorbent assay 
technology. Human IL-6 specific-specific polyclonal 
antibodies  has been precoated onto 96-well plates. The 
human specific detection monoclonal antibodies are 
biotinylated. The test samples and biotinylated 
detection antibodies are added to the wells 
subsequently and then followed by washing with PBS 
or TBS buffer. Avidin-Biotin-Peroxidase Complex is 
added and unbound conjugates are washed away with 
PBS or TBS buffer. HRP substrate TMB is used to 
visualize HRP enzymatic reaction. TMB is catalyzed 
by HRP to produce a blue colour product that changed 
into yellow after adding acidic stop solution. The 
density of yellow is proportional to the human IL-6 
amount of sample captured in plate. 
Results 
All subjects completed the entire study. Healing was 
uneventful in all cases. No adverse effects, such as 
discomfort, burning sensation, dentin hypersensitivity, 
or pain related to the laser irradiation were reported by 
any of the subjects. The baseline demographic data of 
the male and female volunteers are given per group in 
Table 1. 
 
Clinical assessments 
The results of the whole-mouth clinical measurements 
(mean±SD) between baseline and time points in test 
and control groups are displayed in Figs. 1 and 2. In 
both groups, all clinical parameters showed statistically 
significant reductions at all time points compared to 
baseline (p<0.05). The mean PD at baseline was 
5.20±0.36 in the laser group and 5.50±0.54  in the 
control group. After treatment, these values became 
3.42±0.32and 3.72.±0.41 at 1 month, 2.97±0.26 and 
3.13±0.24 at 3 months, respectively. The mean CAL at 
baseline was 5.20±0.45 in the laser group 
and5.43±0.52 in the control group. After treatment, 
these values decreased to3.83±0.33  and 3.95±0.28 at 1 
month, 2.03±0.30 and 2.33.±0.47 months, respectively. 
The reduction in PD and CAL was significantly higher 
for the test group (p<0.05). The mean PI at baseline 
was 1.96±0.11 in the laser group and 2.04±0.11 in the 
control group. After treatment, these values were 
1.20±0.08 and 1.44±0.08 at 1 month, 1.05±0.11 and 
1.26±0.08 at 3 months, respectively. The mean GI at 
baseline was1.92±0.12 in the laser group and 
1.91±0.11 in the control group. After treatment, these 
values were reduced to1.19±0.08 and 1.31±0.07 at 1 
month, 0.99±0.08 and1.15±0.09 at 3 months, 
respectively. The mean BOP percentage at baseline 
was 82.24±4.87 in the laser group and 84.40±5.12 in 
the control group. After treatment, these percentages 
changed into 17.55±1.77 and 29.77±1.95 at 1 month, 
11.53±3.50 and 17.60±2.06 at 3 months, respectively. 
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Fig 1:shows that Scaling and Root-Planing with laser are more efficient in reducing Probing depth. 
 
Fig 2:shows that Scaling and Root-Planing with laser are more efficient in gaining Clinical attachment level. 
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Fig 3:shows that Scaling and Root-Planing with Laser are more efficient in reducing Plaque index. 
 
Fig 4:shows that Scaling and Root-Planning with laser are more efficient in reducing gingival index. 
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Fig 5:shows that Scaling and Root-Planning with Laser are more efficient in reducing gingival bleeding index. 
 
 
Changes in cytokine levels in GCF 
IL-6 were assessed in GCF as marker of cytokine-mediated inflammatory response. At baseline, no significant 
differences were found between test and control groups. The mean IL-6 level at baseline was 21.08±4.37 pg/30 s in 
the laser group and 16.79±3.86 pg/30 s in the control group. After treatment, these values were 
8.87±1.77and7.63±1.95 pg/30 s at 1 month, 3.99±1.16 and 4.84±1.96 pg/30 s at 3 months, respectively. After 
treatment, levels of IL-6 significantly reduced at 1 month (p<0.05), stayed low at 3 months (p<0.05). There were no 
statistically significant differences between groups. 
 
Fig 6:shows that Scaling and Root-Planing with laser are more efficient in reducing Interleukin-6. 
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Discussion 
The essential objective of periodontal treatment is to 
decrease or eliminate the responsible periopathogens 
by means of removing bacterial deposit from the tooth 
surface[9]The cytokine interleukin-6 (IL-6) is a major 
mediator of the host response to tissue injury and 
infection. IL-6 plays a major role in B-cell 
differentiation in the immune system. It is also 
accepted that this cytokine has multiple biological 
activities, such as the enhancement of cell proliferation 
and the acceleration of bone resorption[10] It is 
produced by activated macrophages, lymphocytes, and 
adipose tissue, and  pivotal cytokine involved in the 
regulation of host response to infection and tissue 
injury. It is synthesized by different cells, for instance, 
monocytes, fibroblasts, osteoblasts and vascular 
endothelial cells in response to inflammatory 
challenges[11]
 
The diode laser is a semiconductor laser that generally 
includes a combination of gallium (Ga), arsenide (Ar), 
and other elements such as aluminum (Al) and indium 
(In) to convert electrical energy into light energy. The 
wavelength range is about 800–980 nm. The diode 
laser does not interact with dental hard tissues making 
it convenient for soft tissue operations; cutting and 
coagulating gingiva and oral mucosa, soft tissue 
curettage, or sulcular debridement. Moritz et al. have 
demonstrated significant bacterial decrease and 
reduction of inflammation when using a diode laser of 
805 nm wavelength combined with SRP[1]Diode laser 
is used in the current study because of its lower cost, 
portability, perceived ease of use. It can be applied to 
treat soft tissues due to its bactericidal and 
detoxification effects, but in treatment of chronic 
periodontitis, it may be useful as an adjunct to SRP 
because it is unable to remove calculus and bacterial 
deposit[2]
 
The goal of periodontal therapy is to eliminate the 
supra and subgingival deposits from the root surfaces 
in order to prevent disease initiation and progression. 
Mechanical treatment for removal deposits involves 
supra and subgingival scaling and root planing (SRP) 
with substantial clinical efficacy. Mediators of 
inflammation promote extracellular matrix destruction 
in periodontium and stimulate bone resorption. 
Successful treatment of the periodontal diseases and 
the stability of the outcomes have to take these issues 
into account while new approaches and modalities 
should be considered. To this end, lasers could provide 
a good option.
 
Lasers can be effective on oral microbial 
species and “disinfect” the periodontal environment. 
Lasers may also modulate the oral inflammatory 
response[1]
 
We found that both treatment modalities resulted in 
significant improvements in all clinical parameters 
after periodontal treatment. clinical reductions were 
greater in the test group compared to the control group. 
Kreisler et al. suggested that higher reduction in PD 
was probably related to the de-epithelization of the 
periodontal pockets leading to an enhanced connective 
tissue attachment. These studies confirmed that laser 
application provided de-epithelization and resulted in a 
reduced epithelial migration as well as an increased 
connective tissue formation. Our results supported this 
notion and suggested that the penetration of the laser 
may not evoke a substantial inflammatory difference 
compared to the mechanical treatment alone while 
resulting in an enhanced clinical healing. Our clinical 
results are in agreement with those obtained by 
Kreisler et al. who demonstrated differences between 
the groups for PD and CAL[12] In addition, our data 
also support findings by Qadri et al[13]who observed 
differences for laser group in PD, PI, and GI compared 
to conventional treatment. Likewise, Moritz et al. and 
Lui et al. who both demonstrated superior results for 
laser group in the terms of PD and 
BOP[14,15]According to Dukic W et al found that the 
results were significant PD gain in moderate pockets 
during the baseline to 18-week and 6 to 18 week 
periods, whereas no difference was found between 
Laser group and Control group in the remaining 
clinical parameters and indicated that when compared 
to SRP alone, multiple adjunctive applications of a 
980-nm diode laser with SRP showed PD 
improvements only in moderate periodontal 
pockets[16]According to Kamma et al. demonstrated 
that the effect of 980-nm diode-laser-assisted treatment 
with SRP was superior to SRP or laser therapy alone 
for clinical (PD, CAL) and microbial parameters in 
patients with AgP[17]According to Aykol G showed 
that low level laser therapy have more improvement in 
sulcus bleeding index, clinical attachment level and 
probing depth compared to control group and showed 
better result[18]Contrary to our findings, Yilmaz et al. 
and Micheli D et al. suggested that diode   laser did not 
result in any additional clinical benefit when compared 
with conventional treatment. These controversial 
reports might be the result of different wavelengths, 
application power densities (685 nm at 30 mW), and 
application time[19,20]In a recent study, Gokhale et 
al. Reported that diode laser application (980 nm, 2.5 
W) as an adjunct to periodontal flap surgery did not 
improve clinical parameters but its bactericidal effect 
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was clearly evident by greater reduction of colony 
forming units of obligate anaerobes[21] 
Caruso U showed that the additional treatment with 
diode laser may lead to a slight improvement of clinical 
parameters (PPD, CAL, GI, PI) after 4, 8,12 weeks, 
whereas the BOP indices were reduced more in the test 
group than in the control group. The use of diode laser 
as adjunctive therapy to scaling and root planing 
provided no additional clinical and microbiological 
benefit over conventional mechanical treatment[22]
 
Nguyen NT showed that by using the diode laser, 
intragroup analyses showed that sites treated with SRP 
+ L or SRP alone had a statistically significant 
reduction of PD, gain in CAL, and reduction of BOP at 
3 months after treatment but in intergroup analyses 
showed no statistically significant difference in the 
mean change of the clinical parameters between the 
SRP + L and SRP alone groups. SRP + L did not 
enhance clinical outcomes compared to SRP alone in 
the treatment of inflamed sites with 5 mm PD it is 
confirmed[5]Contrary to our findings, Lui suggested 
that low power laser did not result in any additional 
clinical benefit[15]
 
The differences between these 
studies may be due to laser wavelength (635–830 
versus 940 nm in our study), energy density (4.5– 8.75 
versus 15 J/cm2 in our study) and study design 
(quadrants instead of the whole mouth).The intergroup 
comparison of percentage reduction in the IL6 levels at 
1 month and 3 months (from Baseline) between the 
Group I and Group II. There was significantly higher 
reduction in the IL6 levels at 1 month and 3 month 
time interval for the Group I as compared to Group II. 
Further the intra group comparison of the IL6 levels 
between the three time intervals was statistically 
significant for Both Group I and Group II (p=0.001) In 
this study, GCF IL-6 levels decreased, significantly in 
both groups after treatment compared to baseline. 
Saglam M supported in favour of all these clinical 
parameter which are present in this study[1]The current 
study is designed to test if the diode laser will enhance 
the treatment outcomes of the SRP in periodontitis and 
this will be accompanied by the changes in the levels 
of mediators of inflammation and tissue turnover. More 
vigorous work needs to be done to confirm the 
usefulness of the diode laser with SRP which would 
greatly facilitate the treatment of periodontal diseases.
 
Conclusion 
Use of the diode laser as an adjunct to scaling and root 
planning produces significant improvement in the 
whole-mouth clinical parameters compared to 
conventional treatment. When biochemical parameters 
were compared between groups, laser with SRP group 
has been shown to be more effective than the 
mechanical treatment in reducing the GCF Interleukin-
6 levels. Therefore, within the limits of this study it can 
be concluded that diode laser as an adjunct to the non-
surgical periodontal therapy is effective for the 
treatment of chronic periodontitis. The limitation to 
this study could be small sample size and observation 
period. Hence, more rigorous work needs to be done to 
confirm the usefulness of the diode laser with SRP 
which would greatly facilitate the treatment of 
periodontal diseases. 
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